Skip to content

A multi-center, randomized, parallel-group, inferiority study to compare the delivery way of novel through-the-scope SEM airway stent delivery system versus Chinese over- the -wire stent (Nanjing Micro-Tech company) SEM airway stent delivery system in the treatment of patients with malignant central airway stenosis.

A multi-center, randomized, parallel-group, inferiority study to compare the delivery way of novel through-the-scope SEM airway stent delivery system versus Chinese over- the -wire stent (Nanjing Micro-Tech company) SEM airway stent delivery system in the treatment of patients with malignant central airway stenosis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17011431
Enrollment
Unknown
Registered
2017-05-18
Start date
2017-05-31
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant central airway stenosis

Interventions

test group:The stent was implanted with a soft bronchoscope
Control group: The stent is implanted through the guide wire

Sponsors

the First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 75 year men and women; 2. The participants or legal authorized person known the purpose and procedure of the clinical trial and voluntarily signed the informed consent; 3. the participants diagnosed malignant central airway obstraction, which airway stensis is more than 50% by CT scan and need to be treatment by implanting with airway stent; 4. Female participants in the screening visit is not in the lactation period, beyond 1 year without breastfeeding and pregnancy plan after surgery; 5. Don't tolerate surgery or want surgery.

Exclusion criteria

Exclusion criteria: 1. lesions are near the carina and need implant Y -stent therapy; 2. the diameter of normal airway is more than 20mm; 3. Treated without subjective intention; 4. the distal stenosis condition can not be projected,doctor think the effective of stent treatment is not good; 5. Don't cooperate with surgery or signed preoperative informed consent; 6. Severe arrhythmia, acute myocardial ischemia, uncontrollable hypertensive crisis; 7. Coagulation dysfunction(PT>2N or PLT <50×10^9/L); 8. Severe organ dysfunction (Shock, severe liver and kidney dysfunction, upper gastrointestinal bleeding, DIC, massive hemoptys); 9. Allergy to narcotic drugs; 10. Pregnancy woman.

Design outcomes

Primary

MeasureTime frame
Operation time of airway stent implantation;

Secondary

MeasureTime frame
Effective rate of clinical treatment of airway stenosis;The success rate of the release of the stent once;to evaluate the safety of the stent;

Countries

China

Contacts

Public ContactJian'an Huang

the First Affiliated Hospital of Soochow University

huang-jian-an@163.com+86 13506218900

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026